Pharma Patents in Canada:
New Regulations & Impacts

Smart & Biggar is pleased to present a timely update on the upcoming changes and impacts to the regulations for pharmaceutical patents in Canada (taking effect September 21, 2017).
 If you have previously registered for this event, please login below:

Registration is required to attend this event. Please register now.
First Name*
Last Name*
 By checking this box, I agree to receive or continue to receive electronic messages such as newsletters and event invitations from Smart & Biggar.
You must have Javascript and Cookies enabled to access this webcast. Click here for Help.
Please enable Cookies in your browser before registering for the webcast.
*Denotes required.

Watch this to learn more from our Life Sciences partners about: patent linkage and patent term restoration; amendments to the Patent Act and Regulations Amending the Patented Medicines (Notice of Compliance) Regulations; new Certificate of Supplementary Protection Regulations, and the long lasting impact to innovators in terms of exclusivity and drug product life-cycle management.

Daphne Lainson, Partner
Life Sciences — Patent Prosecution,
Regulatory & Compliance

Sheldon Hamilton, Partner
Life Sciences – Pharmaceutical Litigation